![](https://i.kinja-img.com/image/upload/c_fit,fl_progressive,q_80,w_636/9c0cfe669ac7ecd9f66727afe39ffaf2.jpg)
New research appears to show that a ketamine-based nasal spray can outmatch a standard option for people with treatment-resistant depression. The large clinical trial found that people taking the spray in combination with other antidepressants were more likely to experience a sustained remission of their symptoms than…